This article has been updated to include comments from a McKesson official.
NEW YORK (GenomeWeb News) – McKesson today announced that it would offer a personalized medicine knowledge service developed by privately held Proventys.
Durham, NC-based Proventys translates predictive data from traditional and emerging diagnostic tests — including genomics, proteomics, and metabolomics — into clinical decision support products.
The firms will develop decision-support solutions that will work with McKesson's clinical applications that incorporate clinical, environmental, and genomic information to help providers determine the best course of treatment for an individual patient, Andrew Mellin, vice president of advanced clinical technology, McKesson Provider Technologies, told GenomeWeb Daily News via e-mail.
"We see Proventys’ solutions as having applicability to a broad spectrum of users in healthcare," said Mellin. "Certainly, physicians will benefit from having this type of information to provide more informed, individualized decisions. We also see these tools being helpful for payors and other constituents in healthcare."
Proventys’ knowledge base will be added to McKesson’s Horizon Knowledge Center clinical content offering, the Atlanta-based firm said in a statement. Mellin added that Proventys' risk-prediction capabilities may eventually be incorporated into a broader suite of healthcare solutions from McKesson.